Matthew Taylor
Stock Analyst at Jefferies
(2.68)
# 1,871
Out of 5,182 analysts
184
Total ratings
59.82%
Success rate
10.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Buy | $220 → $190 | $154.96 | +22.61% | 5 | Feb 10, 2026 | |
| PEN Penumbra | Downgrades: Hold | $335 → $374 | $329.96 | +13.35% | 2 | Jan 16, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $69.73 | +50.58% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $202.46 | +75.34% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $80.84 | +21.23% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $14.50 | +31.03% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $101.83 | +42.39% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $13.65 | +9.89% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $86.42 | -12.06% | 17 | May 24, 2024 | |
| MASI Masimo | Downgrades: Hold | $107 → $121 | $178.73 | -32.30% | 9 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.26 | +228.64% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $18.28 | +146.17% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $6.76 | +47.93% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $9.33 | +468.06% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $10.59 | +126.63% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $332.07 | +3.89% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $91.40 | +42.23% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $13.17 | +51.86% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $34.54 | +146.09% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $90.00 | -16.67% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $226.05 | +8.38% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $16.62 | +273.04% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $115.51 | +81.80% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $11.03 | +8.79% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $63.11 | +98.07% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $61.86 | -19.17% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $452.95 | -53.64% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $63.54 | +51.09% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $4.05 | +72.84% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $9.70 | +64.95% | 2 | Jul 19, 2017 |
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Buy
Price Target: $220 → $190
Current: $154.96
Upside: +22.61%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $335 → $374
Current: $329.96
Upside: +13.35%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $69.73
Upside: +50.58%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $202.46
Upside: +75.34%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $80.84
Upside: +21.23%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $14.50
Upside: +31.03%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $101.83
Upside: +42.39%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $13.65
Upside: +9.89%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $86.42
Upside: -12.06%
Masimo
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $178.73
Upside: -32.30%
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $4.26
Upside: +228.64%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $18.28
Upside: +146.17%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $6.76
Upside: +47.93%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $9.33
Upside: +468.06%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $10.59
Upside: +126.63%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $332.07
Upside: +3.89%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $91.40
Upside: +42.23%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $13.17
Upside: +51.86%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $34.54
Upside: +146.09%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $90.00
Upside: -16.67%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $226.05
Upside: +8.38%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $16.62
Upside: +273.04%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $115.51
Upside: +81.80%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $11.03
Upside: +8.79%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $63.11
Upside: +98.07%
Oct 12, 2022
Initiates: Buy
Price Target: $50
Current: $61.86
Upside: -19.17%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $452.95
Upside: -53.64%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $63.54
Upside: +51.09%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $4.05
Upside: +72.84%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $9.70
Upside: +64.95%